Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is to provide continued acess to immunosuppressive medications
to subjects from the completed/closed trial ITN005CT (NIS01,NCT00014911). THIS PROTOCOL DOES
NOT PROVIDE MEDICINES TO DIABETES PATIENTS WHO DID NOT PARTICIPATE IN ITN005CT.
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)